Knowledge Ecology International

Distributed earlier on Wikileaks, this is reportedly is an internal Sun document, discussing a strategy to migrate Oracle users to MySQL.

“Project Peter is an internal effort to assist Sun / MySQL customers in migrating from Oracle to MySQL by offering them a comprehensive solution that consists of Professional Services, Best Practices, and a set of approved third party migration tools and utilities that will enable them to move to MySQL in a way that is as easy as possible.”

Continue Reading →

The Wellcome Trust convened an “Opinion Formers Conference” on “Counterfeit Medicines: Perspectives and Action” on Monday 26 October 2009. Continue Reading →

USPTO has sent KEI a letter, rejecting our request for a fee waiver for processing a September 30, 2009, freedom of information Act (FOIA) request. The FOIA focused on these items:

Continue Reading →

Updated October 16, 2009, 11:10 am

Continue Reading →

On November 4-6, 2009, the next round of negotiations for the Anti-Counterfeiting Trade Negotiations (ACTA) will take place in Seoul, Korea. The following is another strange chapter in the secrecy surrounding this negotiation.

Background

Since ACTA was first announced, KEI has pressed the negotiating governments to provide more transparency, including recently, for example

Continue Reading →

The World Intellectual Property Organization has convened an “Open-Ended Forum on Proposed Development Agenda Projects” (October 13-14, 2009). According to WIPO,

Continue Reading →

In discussions about a possible WIPO Treaty for persons who are blind or have other reading disabilities, there have been suggestions by some that voluntary licensing by rights holders presents a sufficient solution to the problem. I studied several publications since 1985 to take a closer look at this viewpoint and find out what were the common perceptions.

Continue Reading →

Korean civil society has asked KEI to disseminate this request for solidarity and action in their efforts to reduce the price of Gleevec, a leukemia treatment pill. The current price is approximately 2,300 USD per month for an adult patient and the Korean government has been sued by Novartis for trying to reduce the price a 14%. Korean civil society is also requesting Novartis to introduce a higher form, 400 mg, in Korea.

REQUEST for Solidarity:

Continue Reading →